Show an ad over header. AMP

I am the FIRST!!!

Gov. Gavin Newsom says California will independently review FDA-approved coronavirus vaccines

California will "independently review" all coronavirus vaccines approved by the federal Food and Drug Administration for distribution, Gov. Gavin Newsom (D) announced at a news conference Monday.

Why it matters: The move that comes days after NAID director Anthony Fauci said he had "strong confidence" in FDA-approved vaccines could cast further public doubt that the federal government could release a vaccine based on political motives, rather than safety and efficacy.


Of note: Newsom said he considers mid-2021 to be a realistic projection for when a vaccine could be publicly distributed, noting the "political polarization" around the issue.

  • "No matter who the next president is, we're going to maintain our vigilance," he added.

What else he's saying: "Of course, we don’t take anyone's word for it," Newsom said, announcing the establishment of the Scientific Safety Review Workgroup.

  • "We will do our own independently reviewed process with our world-class experts.
  • "These experts … will independently review and monitor any vaccine trials to guarantee safety, to guarantee equity and to guarantee the transparency of the distribution of our vaccines."

The big picture: Faucitold CBS Evening News last week that scientists should know by November or December whether potential COVID-19 vaccines are safe and effective and that vaccine candidates undergoing clinical trials could be widely available by April if this is proven to be the case.

  • Health officials testified on Capitol Hill in September that the vaccine approval process would be based on safety and efficacy, not politics.
  • The FDA also stressed in new guidelines last month it would toughen the requirements for a coronavirus vaccine emergency authorization.
  • The FDA did not immediately respond to Axios' request for comment.

regular 4 post ff

infinite scroll 4 pff

A record 44% of the New York Times' subscription growth came from non-news products in Q1

The New York Times on Wednesday said it added 301,000 new digital-only subscribers last quarter, its slowest quarter for digital subscriber growth in over a year.

Yes, but: New subscriber growth was weighted much more heavily this quarter towards non-news products than in any other previous quarter in the company’s history. A record 44% of The Times’ new digital subscribers came from non-core news products, like cooking, games and audio, last quarter.

Keep reading...Show less

Axios-Ipsos poll: Vaccine puts the sparks back in July 4

Data: Axios/Ipsos poll; Chart: Michelle McGhee/Axios

Just four in 10 Americans say attending a Fourth of July celebration this year feels risky — about half as many as a year ago, according to the latest installment of the Axios/Ipsos Coronavirus Index.

The big picture: Our weekly national survey finds broad awareness and concern around the emerging Delta variant. But people's behaviors really aren't changing in the face of that threat.

Keep reading...Show less

Insights

mail-copy

Get Goodhumans in your inbox

Most Read

More Stories
<!ENTITY lol2 “&lol;&lol;&lol;&lol;&lol;&lol;&lol;&lol;&lol;&lol;“> <!ENTITY lol3 “&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;“> <!ENTITY lol4 “&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;“> ]> &lol4;